Skip to main content

Ibrutinib

Severe neutropenia: case report

    Reactions Weekly volume 1900, page 163 (2022)Cite this article

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    USD 49.95

    Price excludes VAT (USA)
    Tax calculation will be finalised during checkout.

    Reference

    • Koehler A, et al. Severe neutropenia in chronic lymphocytic leukemia (CLL) patients treated with ibrutinib. Leukemia and Lymphoma 62 (Suppl.): S184-S186, Jan 2021. Available from: URL: http://doi.org/10.1080/10428194.2021.1995175 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ibrutinib. Reactions Weekly 1900, 163 (2022). https://doi.org/10.1007/s40278-022-12515-9

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40278-022-12515-9